Kevin Hern comments on American strength and leadership

Kevin Hern comments on American strength and leadership
Rep. Kevin Hern, U.S. Representative for Oklahoma's 1st District — LinkedIn
0Comments

Congressman Kevin Hern, who represents Oklahoma’s 1st district in the U.S. Congress, has recently shared a series of tweets expressing his views on current political developments and leadership in the United States.

On February 3, 2025, Congressman Hern tweeted: “American strength is back!” This statement suggests his approval of the current state of national affairs.

Later that day, at 21:55 UTC, Hern praised the President by stating: “Great work, @POTUS! It sure is nice to have the author of THE ART OF THE DEAL in the @WhiteHouse “ His tweet reflects admiration for the President’s approach to governance and negotiations.

On February 4, 2025, Congressman Hern addressed concerns about government spending and oversight. He tweeted: “Democrats and the deep-state, unelected bureaucracy both stand to benefit from runaway government spending, minimal oversight, and a government that’s too big to properly audit. That’s why they’re so resistant to DOGE.” This message criticizes certain political factions for their stance on financial management within government structures.



Related

Sara Brenner, Principal Deputy Commissioner at FDA

43 companies in cities within Tulsa County received 43 inspections in 2025

There were 43 companies in cities associated with Tulsa County that received 43 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sean R. Keveney J.D., Chief Counsel of FDA

Cities located in Osage County saw FDA inspections of 39 companies in 2025

There were 39 companies in cities associated with Osage County that received 39 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Jim Traficant, Chief of Staff of FDA

Wagoner County cities: 39 companies received FDA inspections in 2025

There were 39 companies in cities associated with Wagoner County that received 39 FDA inspections in 2025, according to the U.S. Food and Drug Administration.